Cambridge · Seed–Series A · 9 people tracked
Also known as CURIE BIO OPERATIONS, LLC · Curie Bio Seed
Find your way into Curie.Bio
2,391 people in our graph share verified history with the Curie.Bio team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Curie.Bio is a venture capital firm that invests in early-stage biotech therapeutics companies.
Source: firm website, verified Sep 15, 2026.
Team · 9 people
from curated & public directories
Founder mafia
4 people who came through Curie.Bio went on to found or lead other companies.
What they invest in
from 2 of 3 portfolio companiesAI & Machine Learning ×2Biotech ×2Deep Tech ×1
HQs:United States×2
Investments · 3 tracked
founders shown can be your intro path
Relay Therapeutics develops the Dynamo platform, which applies motion-based drug design principles to discover therapeutic drugs by integrating protein dynamics simulations with experimental and computational techniques.
AI & Machine LearningBiotechDeep TechCambridge, US
Donald A. Bergstrom(Executive Officer)inSanjiv K. Patel(Director, President and Chief Executive Officer)inSekar Kathiresan(Director)Douglas S. Ingram(Director)Mark Murcko(Director)Laura Shawver(Director)
Board seatAlexis Borisy· per SEC Form D · $30M raise · filed Jan 2024
Co-investorsCommonweal VenturesEcoR1 CapitalForesite CapitalNextech InvestSoftBank Vision FundGeneral Catalyst+1 more
.png)
Forward Therapeutics develops oral small-molecule medicines targeting inflammation-driven diseases, using a structure-based, data-driven discovery engine to design drugs against validated pathways.
AI & Machine LearningBiotech
Co-investorsOrbiMed
Social video analytics company providing cross-platform audience and content intelligence; acquired by Chartbeat in March 2023.
Mountain View, US
Robert Gabel(Executive Officer, Director)
BoardMatt Coffin(Director)Rick Heitzmann(Director)inAllen DeBevoise(Director)Warren Lee(Director)in
Co-investorsCanaan PartnersBling CapitalFifth WallFirstMark CapitalLerer HippeauMarker+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
1 IPOs · 1 acquisitions · showing 1RelayNASDAQ: RLAY
Portfolio news
latest coverage across their companiesRelay · investing.com · Aug 20, 2026
Frequently asked questions
- What stage does Curie.Bio invest at?
- Curie.Bio invests at the Seed, Series A stages.
- What is Curie.Bio's typical check size?
- Curie.Bio typically writes checks of $7M.
- What sectors does Curie.Bio focus on?
- Curie.Bio focuses on Biotech.
- Where is Curie.Bio located?
- Curie.Bio is headquartered in Cambridge, US.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.